Jagsonpal Pharma’s board of directors has approved the share buyback price of ₹250 apiece via the tender offer route. Previous Post Crude surge above $100, weak rupee and higher yields weigh on Dalal Street Next Post One global strategist sees a market correction resulting from Iran war fallout. Where to hide Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email and website in this browser for the next time I comment.Post Comment
